Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Study Completion Date

March 31, 2004

Conditions
Head and Neck Cancer
Interventions
DRUG

oxaliplatin

Trial Locations (11)

29605

Cancer Centers of the Carolinas, Greenville

60068

Lutheran General Cancer Care Center, Park Ridge

60201

Evanston Northwestern Health Care, Evanston

60640

Louis A. Weiss Memorial Hospital, Chicago

61602

Oncology/Hematology Associates of Central Illinois, P.C., Peoria

62526

Decatur Memorial Hospital Cancer Care Institute, Decatur

62701

Central Illinois Hematology Oncology Center, Springfield

60637-1470

University of Chicago Cancer Research Center, Chicago

46885-5099

Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne

46634-1935

Saint Joseph's Regional Medical Center, South Bend

43210-1240

Arthur G. James Cancer Hospital - Ohio State University, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT00005035 - Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer | Biotech Hunter | Biotech Hunter